| Treatment group | |||
---|---|---|---|---|
 | Control | 2 weeks | 4 weeks | 6 weeks |
Mf-positives/persons examined | 14/14 | 8/8 | 13/13 | 3/3 |
% of mf-positive patients | 100 % | 100 % | 100 % | 100 % |
GM before treatment | 16.7 | 12.2 | 10.8 | 14.1 |
Percentage of GM | 100 % | 100 % | 100 % | 100 % |
Mf-positives/persons examined | 14/14 | 7/8 | 7/13 | 1/3 |
% of mf-positive patients | 100 % | 87.5 % | 53.8 % | 33.3 % |
GM at 18 months * | 4.1 | 4.3 | 0.7 | 0.1 |
% of pre-treatment GM | 24.6 % | 35.2 % | 6.5 % | 0.7 % |